LDL-IN-3是从专利WO/2005/039596A1，化合物实例C25和专利US6133467，化合物实例3中提取的抗动脉粥样硬化化合物。
CAS：180908-67-2
分子式：C24H36O3Si
分子量：400.63
纯度：98%
存储：Store at -20°C

Background:

LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3.

LDL-IN-3 is antioxidant which inhibits low density lipoprotein (LDL) lipid peroxidation and is useful as anti-atherosclerotic agents[1][2].

LDL-IN-3 decreases serum cholesterol, TBARS and the amount of aortic lesions (57 %) in comparison with control rabbits. LDL-IN-3 is found in very high concentrations in the serum (182.4 μg/mL) and livers (323 μg/mL)[1][2].

[1]. WO/2005/039596A1 [2]. US 6133467